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Dear Dr Weeks, 
 
We recently completed a survey designed to explore consumer perceptions of the effectiveness and 
side-effects of glucosamine. People attending their GP surgery or local pharmacy were invited to 
voluntarily complete our 20-item questionnaire on their use of this glucosamine (both sulphate and 
hydrochloride salts). The results elicited confirmatory findings about consumer’s perception of its 
value in multiple areas.  However, there was an exciting finding we would like to share.  
Five (from 87) participants reported that they had been diagnosed with rheumatoid arthritis.  All five 
reported that they had been taking glucosamine sulfate at the recommended dose of 1500mg per 
day, and had been taking it for six months or longer. All reported they perceived a decrease in pain 
ranging from 1–2 points on the pain visual analogue scale, to the extent they chose to continue 
therapy. They also had improvement in joint function/movement ranging from 1–2 points on a 5-
points movement scale. 
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Looking at the literature, we identified a growing pattern of evidence that may explain this finding. 
The role of reactive oxygen species (ROS) and the resultant oxidative stress found in the 
pathogenesis and progression of rheumatoid arthritis is well understood.  Glucosamine is reported 
to possess antioxidant activity1. Thus, the findings of this study may be rationalised as follows; the 
antioxidant properties may be directly responsible for the positive effects reported by rheumatoid 
arthritis suffers.  
While most studies have investigated the effectiveness of glucosamine in osteoarthritis (a 
predominantly non-inflammatory condition), few have examined its effectiveness in rheumatoid 
arthritis. Nakamura et al. (2007)2 found that glucosamine treatment produced noticeable 
improvements in symptoms of rheumatoid arthritis patients, but antioxidant status was not 
measured.  
In addition, if it has antioxidant effects, glucosamine may also have a role in the treatment of other 
diseases associated with oxidative stress. There are reports on antioxidant properties 3,4,5,6, but we 
found no reports on any proposed anti-inflammatory actions.   
This was an incidental finding in our study in only 5 patients, but we believe that this perceived 
effectiveness warrants further study to identify if this effect is apparent and to elucidate the mode 
of action and regimen. 
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Yours sincerely 
 
 
 
atrick A. Ball, 
